Having a tattoo has been linked to a higher risk of conditions like lymphoma and skin cancer, but the situation isn't ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

BioAFM instruments are designed to measure soft, fragile, and complex samples, including single molecules, nucleic acids, ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children, paving ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest ...

This study reveals that Fe-doped boron nitride nanoparticles improve Anastrozole delivery, offering enhanced stability and targeted therapy for breast cancer.

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders through targeted drug delivery.

A Massachusetts company is transforming the way breast cancer is detected in real time. Newton-based Lumicell launched its ...

At a press conference at the Baptist Health IcePlex, the American Cancer Society (ACS) announced today the launch of ...